Medical Care
Global Proteomic Biomarker Market Research Report 2025
- May 05, 25
- ID: 228128
- Pages: 106
- Figures: 108
- Views: 6
The global market for Proteomic Biomarker was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Proteomic biomarkers are thus protein indicators of biological processes that are typically discovered through the analysis of a cell protein library in a diseased and/or nondiseased state.
The market in Asia Pacific is also growing rapidly during the forecast period owing to the increasing focus on precision medicine in the region and the growing burden of diseases such as cancer and cardiovascular diseases in the region.
This report aims to provide a comprehensive presentation of the global market for Proteomic Biomarker, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Proteomic Biomarker.
The Proteomic Biomarker market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Proteomic Biomarker market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Proteomic Biomarker companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Laboratories
Agilent/Dako
Amprion
BasePair Biotechnologies
Beckman Coulter Diagnostics
Becton, Dickinson and Company
Bio-Rad Laboratories, Inc.
Bio-Techne
Bruker
C2N Diagnostics
Cepheid (Danaher)
Diadem Diagnostics
Eve Technologies
Fluidic Analytics
Fujirebio
Hybrigenics Services
Luminex Corp (DiaSorin)
NanoDx
Nautilus Biotechnology
Nicoya
Olink
Qiagen
Segment by Type
Mass spectrometry
Chromatography
Blotting
Others
Segment by Application
Bio Industry
Medical Industry
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Proteomic Biomarker company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Proteomic biomarkers are thus protein indicators of biological processes that are typically discovered through the analysis of a cell protein library in a diseased and/or nondiseased state.
The market in Asia Pacific is also growing rapidly during the forecast period owing to the increasing focus on precision medicine in the region and the growing burden of diseases such as cancer and cardiovascular diseases in the region.
This report aims to provide a comprehensive presentation of the global market for Proteomic Biomarker, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Proteomic Biomarker.
The Proteomic Biomarker market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Proteomic Biomarker market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Proteomic Biomarker companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Laboratories
Agilent/Dako
Amprion
BasePair Biotechnologies
Beckman Coulter Diagnostics
Becton, Dickinson and Company
Bio-Rad Laboratories, Inc.
Bio-Techne
Bruker
C2N Diagnostics
Cepheid (Danaher)
Diadem Diagnostics
Eve Technologies
Fluidic Analytics
Fujirebio
Hybrigenics Services
Luminex Corp (DiaSorin)
NanoDx
Nautilus Biotechnology
Nicoya
Olink
Qiagen
Segment by Type
Mass spectrometry
Chromatography
Blotting
Others
Segment by Application
Bio Industry
Medical Industry
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Proteomic Biomarker company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Proteomic Biomarker Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Mass spectrometry
1.2.3 Chromatography
1.2.4 Blotting
1.2.5 Others
1.3 Market by Application
1.3.1 Global Proteomic Biomarker Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Bio Industry
1.3.3 Medical Industry
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Proteomic Biomarker Market Perspective (2020-2031)
2.2 Global Proteomic Biomarker Growth Trends by Region
2.2.1 Global Proteomic Biomarker Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Proteomic Biomarker Historic Market Size by Region (2020-2025)
2.2.3 Proteomic Biomarker Forecasted Market Size by Region (2026-2031)
2.3 Proteomic Biomarker Market Dynamics
2.3.1 Proteomic Biomarker Industry Trends
2.3.2 Proteomic Biomarker Market Drivers
2.3.3 Proteomic Biomarker Market Challenges
2.3.4 Proteomic Biomarker Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Proteomic Biomarker Players by Revenue
3.1.1 Global Top Proteomic Biomarker Players by Revenue (2020-2025)
3.1.2 Global Proteomic Biomarker Revenue Market Share by Players (2020-2025)
3.2 Global Proteomic Biomarker Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Proteomic Biomarker Revenue
3.4 Global Proteomic Biomarker Market Concentration Ratio
3.4.1 Global Proteomic Biomarker Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Proteomic Biomarker Revenue in 2024
3.5 Global Key Players of Proteomic Biomarker Head office and Area Served
3.6 Global Key Players of Proteomic Biomarker, Product and Application
3.7 Global Key Players of Proteomic Biomarker, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Proteomic Biomarker Breakdown Data by Type
4.1 Global Proteomic Biomarker Historic Market Size by Type (2020-2025)
4.2 Global Proteomic Biomarker Forecasted Market Size by Type (2026-2031)
5 Proteomic Biomarker Breakdown Data by Application
5.1 Global Proteomic Biomarker Historic Market Size by Application (2020-2025)
5.2 Global Proteomic Biomarker Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Proteomic Biomarker Market Size (2020-2031)
6.2 North America Proteomic Biomarker Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Proteomic Biomarker Market Size by Country (2020-2025)
6.4 North America Proteomic Biomarker Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Proteomic Biomarker Market Size (2020-2031)
7.2 Europe Proteomic Biomarker Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Proteomic Biomarker Market Size by Country (2020-2025)
7.4 Europe Proteomic Biomarker Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Proteomic Biomarker Market Size (2020-2031)
8.2 Asia-Pacific Proteomic Biomarker Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Proteomic Biomarker Market Size by Region (2020-2025)
8.4 Asia-Pacific Proteomic Biomarker Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Proteomic Biomarker Market Size (2020-2031)
9.2 Latin America Proteomic Biomarker Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Proteomic Biomarker Market Size by Country (2020-2025)
9.4 Latin America Proteomic Biomarker Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Proteomic Biomarker Market Size (2020-2031)
10.2 Middle East & Africa Proteomic Biomarker Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Proteomic Biomarker Market Size by Country (2020-2025)
10.4 Middle East & Africa Proteomic Biomarker Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Proteomic Biomarker Introduction
11.1.4 Abbott Laboratories Revenue in Proteomic Biomarker Business (2020-2025)
11.1.5 Abbott Laboratories Recent Development
11.2 Agilent/Dako
11.2.1 Agilent/Dako Company Details
11.2.2 Agilent/Dako Business Overview
11.2.3 Agilent/Dako Proteomic Biomarker Introduction
11.2.4 Agilent/Dako Revenue in Proteomic Biomarker Business (2020-2025)
11.2.5 Agilent/Dako Recent Development
11.3 Amprion
11.3.1 Amprion Company Details
11.3.2 Amprion Business Overview
11.3.3 Amprion Proteomic Biomarker Introduction
11.3.4 Amprion Revenue in Proteomic Biomarker Business (2020-2025)
11.3.5 Amprion Recent Development
11.4 BasePair Biotechnologies
11.4.1 BasePair Biotechnologies Company Details
11.4.2 BasePair Biotechnologies Business Overview
11.4.3 BasePair Biotechnologies Proteomic Biomarker Introduction
11.4.4 BasePair Biotechnologies Revenue in Proteomic Biomarker Business (2020-2025)
11.4.5 BasePair Biotechnologies Recent Development
11.5 Beckman Coulter Diagnostics
11.5.1 Beckman Coulter Diagnostics Company Details
11.5.2 Beckman Coulter Diagnostics Business Overview
11.5.3 Beckman Coulter Diagnostics Proteomic Biomarker Introduction
11.5.4 Beckman Coulter Diagnostics Revenue in Proteomic Biomarker Business (2020-2025)
11.5.5 Beckman Coulter Diagnostics Recent Development
11.6 Becton, Dickinson and Company
11.6.1 Becton, Dickinson and Company Company Details
11.6.2 Becton, Dickinson and Company Business Overview
11.6.3 Becton, Dickinson and Company Proteomic Biomarker Introduction
11.6.4 Becton, Dickinson and Company Revenue in Proteomic Biomarker Business (2020-2025)
11.6.5 Becton, Dickinson and Company Recent Development
11.7 Bio-Rad Laboratories, Inc.
11.7.1 Bio-Rad Laboratories, Inc. Company Details
11.7.2 Bio-Rad Laboratories, Inc. Business Overview
11.7.3 Bio-Rad Laboratories, Inc. Proteomic Biomarker Introduction
11.7.4 Bio-Rad Laboratories, Inc. Revenue in Proteomic Biomarker Business (2020-2025)
11.7.5 Bio-Rad Laboratories, Inc. Recent Development
11.8 Bio-Techne
11.8.1 Bio-Techne Company Details
11.8.2 Bio-Techne Business Overview
11.8.3 Bio-Techne Proteomic Biomarker Introduction
11.8.4 Bio-Techne Revenue in Proteomic Biomarker Business (2020-2025)
11.8.5 Bio-Techne Recent Development
11.9 Bruker
11.9.1 Bruker Company Details
11.9.2 Bruker Business Overview
11.9.3 Bruker Proteomic Biomarker Introduction
11.9.4 Bruker Revenue in Proteomic Biomarker Business (2020-2025)
11.9.5 Bruker Recent Development
11.10 C2N Diagnostics
11.10.1 C2N Diagnostics Company Details
11.10.2 C2N Diagnostics Business Overview
11.10.3 C2N Diagnostics Proteomic Biomarker Introduction
11.10.4 C2N Diagnostics Revenue in Proteomic Biomarker Business (2020-2025)
11.10.5 C2N Diagnostics Recent Development
11.11 Cepheid (Danaher)
11.11.1 Cepheid (Danaher) Company Details
11.11.2 Cepheid (Danaher) Business Overview
11.11.3 Cepheid (Danaher) Proteomic Biomarker Introduction
11.11.4 Cepheid (Danaher) Revenue in Proteomic Biomarker Business (2020-2025)
11.11.5 Cepheid (Danaher) Recent Development
11.12 Diadem Diagnostics
11.12.1 Diadem Diagnostics Company Details
11.12.2 Diadem Diagnostics Business Overview
11.12.3 Diadem Diagnostics Proteomic Biomarker Introduction
11.12.4 Diadem Diagnostics Revenue in Proteomic Biomarker Business (2020-2025)
11.12.5 Diadem Diagnostics Recent Development
11.13 Eve Technologies
11.13.1 Eve Technologies Company Details
11.13.2 Eve Technologies Business Overview
11.13.3 Eve Technologies Proteomic Biomarker Introduction
11.13.4 Eve Technologies Revenue in Proteomic Biomarker Business (2020-2025)
11.13.5 Eve Technologies Recent Development
11.14 Fluidic Analytics
11.14.1 Fluidic Analytics Company Details
11.14.2 Fluidic Analytics Business Overview
11.14.3 Fluidic Analytics Proteomic Biomarker Introduction
11.14.4 Fluidic Analytics Revenue in Proteomic Biomarker Business (2020-2025)
11.14.5 Fluidic Analytics Recent Development
11.15 Fujirebio
11.15.1 Fujirebio Company Details
11.15.2 Fujirebio Business Overview
11.15.3 Fujirebio Proteomic Biomarker Introduction
11.15.4 Fujirebio Revenue in Proteomic Biomarker Business (2020-2025)
11.15.5 Fujirebio Recent Development
11.16 Hybrigenics Services
11.16.1 Hybrigenics Services Company Details
11.16.2 Hybrigenics Services Business Overview
11.16.3 Hybrigenics Services Proteomic Biomarker Introduction
11.16.4 Hybrigenics Services Revenue in Proteomic Biomarker Business (2020-2025)
11.16.5 Hybrigenics Services Recent Development
11.17 Luminex Corp (DiaSorin)
11.17.1 Luminex Corp (DiaSorin) Company Details
11.17.2 Luminex Corp (DiaSorin) Business Overview
11.17.3 Luminex Corp (DiaSorin) Proteomic Biomarker Introduction
11.17.4 Luminex Corp (DiaSorin) Revenue in Proteomic Biomarker Business (2020-2025)
11.17.5 Luminex Corp (DiaSorin) Recent Development
11.18 NanoDx
11.18.1 NanoDx Company Details
11.18.2 NanoDx Business Overview
11.18.3 NanoDx Proteomic Biomarker Introduction
11.18.4 NanoDx Revenue in Proteomic Biomarker Business (2020-2025)
11.18.5 NanoDx Recent Development
11.19 Nautilus Biotechnology
11.19.1 Nautilus Biotechnology Company Details
11.19.2 Nautilus Biotechnology Business Overview
11.19.3 Nautilus Biotechnology Proteomic Biomarker Introduction
11.19.4 Nautilus Biotechnology Revenue in Proteomic Biomarker Business (2020-2025)
11.19.5 Nautilus Biotechnology Recent Development
11.20 Nicoya
11.20.1 Nicoya Company Details
11.20.2 Nicoya Business Overview
11.20.3 Nicoya Proteomic Biomarker Introduction
11.20.4 Nicoya Revenue in Proteomic Biomarker Business (2020-2025)
11.20.5 Nicoya Recent Development
11.21 Olink
11.21.1 Olink Company Details
11.21.2 Olink Business Overview
11.21.3 Olink Proteomic Biomarker Introduction
11.21.4 Olink Revenue in Proteomic Biomarker Business (2020-2025)
11.21.5 Olink Recent Development
11.22 Qiagen
11.22.1 Qiagen Company Details
11.22.2 Qiagen Business Overview
11.22.3 Qiagen Proteomic Biomarker Introduction
11.22.4 Qiagen Revenue in Proteomic Biomarker Business (2020-2025)
11.22.5 Qiagen Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Proteomic Biomarker Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Mass spectrometry
1.2.3 Chromatography
1.2.4 Blotting
1.2.5 Others
1.3 Market by Application
1.3.1 Global Proteomic Biomarker Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Bio Industry
1.3.3 Medical Industry
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Proteomic Biomarker Market Perspective (2020-2031)
2.2 Global Proteomic Biomarker Growth Trends by Region
2.2.1 Global Proteomic Biomarker Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Proteomic Biomarker Historic Market Size by Region (2020-2025)
2.2.3 Proteomic Biomarker Forecasted Market Size by Region (2026-2031)
2.3 Proteomic Biomarker Market Dynamics
2.3.1 Proteomic Biomarker Industry Trends
2.3.2 Proteomic Biomarker Market Drivers
2.3.3 Proteomic Biomarker Market Challenges
2.3.4 Proteomic Biomarker Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Proteomic Biomarker Players by Revenue
3.1.1 Global Top Proteomic Biomarker Players by Revenue (2020-2025)
3.1.2 Global Proteomic Biomarker Revenue Market Share by Players (2020-2025)
3.2 Global Proteomic Biomarker Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Proteomic Biomarker Revenue
3.4 Global Proteomic Biomarker Market Concentration Ratio
3.4.1 Global Proteomic Biomarker Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Proteomic Biomarker Revenue in 2024
3.5 Global Key Players of Proteomic Biomarker Head office and Area Served
3.6 Global Key Players of Proteomic Biomarker, Product and Application
3.7 Global Key Players of Proteomic Biomarker, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Proteomic Biomarker Breakdown Data by Type
4.1 Global Proteomic Biomarker Historic Market Size by Type (2020-2025)
4.2 Global Proteomic Biomarker Forecasted Market Size by Type (2026-2031)
5 Proteomic Biomarker Breakdown Data by Application
5.1 Global Proteomic Biomarker Historic Market Size by Application (2020-2025)
5.2 Global Proteomic Biomarker Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Proteomic Biomarker Market Size (2020-2031)
6.2 North America Proteomic Biomarker Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Proteomic Biomarker Market Size by Country (2020-2025)
6.4 North America Proteomic Biomarker Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Proteomic Biomarker Market Size (2020-2031)
7.2 Europe Proteomic Biomarker Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Proteomic Biomarker Market Size by Country (2020-2025)
7.4 Europe Proteomic Biomarker Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Proteomic Biomarker Market Size (2020-2031)
8.2 Asia-Pacific Proteomic Biomarker Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Proteomic Biomarker Market Size by Region (2020-2025)
8.4 Asia-Pacific Proteomic Biomarker Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Proteomic Biomarker Market Size (2020-2031)
9.2 Latin America Proteomic Biomarker Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Proteomic Biomarker Market Size by Country (2020-2025)
9.4 Latin America Proteomic Biomarker Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Proteomic Biomarker Market Size (2020-2031)
10.2 Middle East & Africa Proteomic Biomarker Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Proteomic Biomarker Market Size by Country (2020-2025)
10.4 Middle East & Africa Proteomic Biomarker Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Proteomic Biomarker Introduction
11.1.4 Abbott Laboratories Revenue in Proteomic Biomarker Business (2020-2025)
11.1.5 Abbott Laboratories Recent Development
11.2 Agilent/Dako
11.2.1 Agilent/Dako Company Details
11.2.2 Agilent/Dako Business Overview
11.2.3 Agilent/Dako Proteomic Biomarker Introduction
11.2.4 Agilent/Dako Revenue in Proteomic Biomarker Business (2020-2025)
11.2.5 Agilent/Dako Recent Development
11.3 Amprion
11.3.1 Amprion Company Details
11.3.2 Amprion Business Overview
11.3.3 Amprion Proteomic Biomarker Introduction
11.3.4 Amprion Revenue in Proteomic Biomarker Business (2020-2025)
11.3.5 Amprion Recent Development
11.4 BasePair Biotechnologies
11.4.1 BasePair Biotechnologies Company Details
11.4.2 BasePair Biotechnologies Business Overview
11.4.3 BasePair Biotechnologies Proteomic Biomarker Introduction
11.4.4 BasePair Biotechnologies Revenue in Proteomic Biomarker Business (2020-2025)
11.4.5 BasePair Biotechnologies Recent Development
11.5 Beckman Coulter Diagnostics
11.5.1 Beckman Coulter Diagnostics Company Details
11.5.2 Beckman Coulter Diagnostics Business Overview
11.5.3 Beckman Coulter Diagnostics Proteomic Biomarker Introduction
11.5.4 Beckman Coulter Diagnostics Revenue in Proteomic Biomarker Business (2020-2025)
11.5.5 Beckman Coulter Diagnostics Recent Development
11.6 Becton, Dickinson and Company
11.6.1 Becton, Dickinson and Company Company Details
11.6.2 Becton, Dickinson and Company Business Overview
11.6.3 Becton, Dickinson and Company Proteomic Biomarker Introduction
11.6.4 Becton, Dickinson and Company Revenue in Proteomic Biomarker Business (2020-2025)
11.6.5 Becton, Dickinson and Company Recent Development
11.7 Bio-Rad Laboratories, Inc.
11.7.1 Bio-Rad Laboratories, Inc. Company Details
11.7.2 Bio-Rad Laboratories, Inc. Business Overview
11.7.3 Bio-Rad Laboratories, Inc. Proteomic Biomarker Introduction
11.7.4 Bio-Rad Laboratories, Inc. Revenue in Proteomic Biomarker Business (2020-2025)
11.7.5 Bio-Rad Laboratories, Inc. Recent Development
11.8 Bio-Techne
11.8.1 Bio-Techne Company Details
11.8.2 Bio-Techne Business Overview
11.8.3 Bio-Techne Proteomic Biomarker Introduction
11.8.4 Bio-Techne Revenue in Proteomic Biomarker Business (2020-2025)
11.8.5 Bio-Techne Recent Development
11.9 Bruker
11.9.1 Bruker Company Details
11.9.2 Bruker Business Overview
11.9.3 Bruker Proteomic Biomarker Introduction
11.9.4 Bruker Revenue in Proteomic Biomarker Business (2020-2025)
11.9.5 Bruker Recent Development
11.10 C2N Diagnostics
11.10.1 C2N Diagnostics Company Details
11.10.2 C2N Diagnostics Business Overview
11.10.3 C2N Diagnostics Proteomic Biomarker Introduction
11.10.4 C2N Diagnostics Revenue in Proteomic Biomarker Business (2020-2025)
11.10.5 C2N Diagnostics Recent Development
11.11 Cepheid (Danaher)
11.11.1 Cepheid (Danaher) Company Details
11.11.2 Cepheid (Danaher) Business Overview
11.11.3 Cepheid (Danaher) Proteomic Biomarker Introduction
11.11.4 Cepheid (Danaher) Revenue in Proteomic Biomarker Business (2020-2025)
11.11.5 Cepheid (Danaher) Recent Development
11.12 Diadem Diagnostics
11.12.1 Diadem Diagnostics Company Details
11.12.2 Diadem Diagnostics Business Overview
11.12.3 Diadem Diagnostics Proteomic Biomarker Introduction
11.12.4 Diadem Diagnostics Revenue in Proteomic Biomarker Business (2020-2025)
11.12.5 Diadem Diagnostics Recent Development
11.13 Eve Technologies
11.13.1 Eve Technologies Company Details
11.13.2 Eve Technologies Business Overview
11.13.3 Eve Technologies Proteomic Biomarker Introduction
11.13.4 Eve Technologies Revenue in Proteomic Biomarker Business (2020-2025)
11.13.5 Eve Technologies Recent Development
11.14 Fluidic Analytics
11.14.1 Fluidic Analytics Company Details
11.14.2 Fluidic Analytics Business Overview
11.14.3 Fluidic Analytics Proteomic Biomarker Introduction
11.14.4 Fluidic Analytics Revenue in Proteomic Biomarker Business (2020-2025)
11.14.5 Fluidic Analytics Recent Development
11.15 Fujirebio
11.15.1 Fujirebio Company Details
11.15.2 Fujirebio Business Overview
11.15.3 Fujirebio Proteomic Biomarker Introduction
11.15.4 Fujirebio Revenue in Proteomic Biomarker Business (2020-2025)
11.15.5 Fujirebio Recent Development
11.16 Hybrigenics Services
11.16.1 Hybrigenics Services Company Details
11.16.2 Hybrigenics Services Business Overview
11.16.3 Hybrigenics Services Proteomic Biomarker Introduction
11.16.4 Hybrigenics Services Revenue in Proteomic Biomarker Business (2020-2025)
11.16.5 Hybrigenics Services Recent Development
11.17 Luminex Corp (DiaSorin)
11.17.1 Luminex Corp (DiaSorin) Company Details
11.17.2 Luminex Corp (DiaSorin) Business Overview
11.17.3 Luminex Corp (DiaSorin) Proteomic Biomarker Introduction
11.17.4 Luminex Corp (DiaSorin) Revenue in Proteomic Biomarker Business (2020-2025)
11.17.5 Luminex Corp (DiaSorin) Recent Development
11.18 NanoDx
11.18.1 NanoDx Company Details
11.18.2 NanoDx Business Overview
11.18.3 NanoDx Proteomic Biomarker Introduction
11.18.4 NanoDx Revenue in Proteomic Biomarker Business (2020-2025)
11.18.5 NanoDx Recent Development
11.19 Nautilus Biotechnology
11.19.1 Nautilus Biotechnology Company Details
11.19.2 Nautilus Biotechnology Business Overview
11.19.3 Nautilus Biotechnology Proteomic Biomarker Introduction
11.19.4 Nautilus Biotechnology Revenue in Proteomic Biomarker Business (2020-2025)
11.19.5 Nautilus Biotechnology Recent Development
11.20 Nicoya
11.20.1 Nicoya Company Details
11.20.2 Nicoya Business Overview
11.20.3 Nicoya Proteomic Biomarker Introduction
11.20.4 Nicoya Revenue in Proteomic Biomarker Business (2020-2025)
11.20.5 Nicoya Recent Development
11.21 Olink
11.21.1 Olink Company Details
11.21.2 Olink Business Overview
11.21.3 Olink Proteomic Biomarker Introduction
11.21.4 Olink Revenue in Proteomic Biomarker Business (2020-2025)
11.21.5 Olink Recent Development
11.22 Qiagen
11.22.1 Qiagen Company Details
11.22.2 Qiagen Business Overview
11.22.3 Qiagen Proteomic Biomarker Introduction
11.22.4 Qiagen Revenue in Proteomic Biomarker Business (2020-2025)
11.22.5 Qiagen Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Proteomic Biomarker Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Mass spectrometry
Table 3. Key Players of Chromatography
Table 4. Key Players of Blotting
Table 5. Key Players of Others
Table 6. Global Proteomic Biomarker Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Proteomic Biomarker Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Proteomic Biomarker Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Proteomic Biomarker Market Share by Region (2020-2025)
Table 10. Global Proteomic Biomarker Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Proteomic Biomarker Market Share by Region (2026-2031)
Table 12. Proteomic Biomarker Market Trends
Table 13. Proteomic Biomarker Market Drivers
Table 14. Proteomic Biomarker Market Challenges
Table 15. Proteomic Biomarker Market Restraints
Table 16. Global Proteomic Biomarker Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Proteomic Biomarker Market Share by Players (2020-2025)
Table 18. Global Top Proteomic Biomarker Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Proteomic Biomarker as of 2024)
Table 19. Ranking of Global Top Proteomic Biomarker Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Proteomic Biomarker Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Proteomic Biomarker, Headquarters and Area Served
Table 22. Global Key Players of Proteomic Biomarker, Product and Application
Table 23. Global Key Players of Proteomic Biomarker, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Proteomic Biomarker Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Proteomic Biomarker Revenue Market Share by Type (2020-2025)
Table 27. Global Proteomic Biomarker Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Proteomic Biomarker Revenue Market Share by Type (2026-2031)
Table 29. Global Proteomic Biomarker Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Proteomic Biomarker Revenue Market Share by Application (2020-2025)
Table 31. Global Proteomic Biomarker Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Proteomic Biomarker Revenue Market Share by Application (2026-2031)
Table 33. North America Proteomic Biomarker Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Proteomic Biomarker Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Proteomic Biomarker Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Proteomic Biomarker Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Proteomic Biomarker Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Proteomic Biomarker Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Proteomic Biomarker Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Proteomic Biomarker Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Proteomic Biomarker Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Proteomic Biomarker Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Proteomic Biomarker Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Proteomic Biomarker Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Proteomic Biomarker Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Proteomic Biomarker Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Proteomic Biomarker Market Size by Country (2026-2031) & (US$ Million)
Table 48. Abbott Laboratories Company Details
Table 49. Abbott Laboratories Business Overview
Table 50. Abbott Laboratories Proteomic Biomarker Product
Table 51. Abbott Laboratories Revenue in Proteomic Biomarker Business (2020-2025) & (US$ Million)
Table 52. Abbott Laboratories Recent Development
Table 53. Agilent/Dako Company Details
Table 54. Agilent/Dako Business Overview
Table 55. Agilent/Dako Proteomic Biomarker Product
Table 56. Agilent/Dako Revenue in Proteomic Biomarker Business (2020-2025) & (US$ Million)
Table 57. Agilent/Dako Recent Development
Table 58. Amprion Company Details
Table 59. Amprion Business Overview
Table 60. Amprion Proteomic Biomarker Product
Table 61. Amprion Revenue in Proteomic Biomarker Business (2020-2025) & (US$ Million)
Table 62. Amprion Recent Development
Table 63. BasePair Biotechnologies Company Details
Table 64. BasePair Biotechnologies Business Overview
Table 65. BasePair Biotechnologies Proteomic Biomarker Product
Table 66. BasePair Biotechnologies Revenue in Proteomic Biomarker Business (2020-2025) & (US$ Million)
Table 67. BasePair Biotechnologies Recent Development
Table 68. Beckman Coulter Diagnostics Company Details
Table 69. Beckman Coulter Diagnostics Business Overview
Table 70. Beckman Coulter Diagnostics Proteomic Biomarker Product
Table 71. Beckman Coulter Diagnostics Revenue in Proteomic Biomarker Business (2020-2025) & (US$ Million)
Table 72. Beckman Coulter Diagnostics Recent Development
Table 73. Becton, Dickinson and Company Company Details
Table 74. Becton, Dickinson and Company Business Overview
Table 75. Becton, Dickinson and Company Proteomic Biomarker Product
Table 76. Becton, Dickinson and Company Revenue in Proteomic Biomarker Business (2020-2025) & (US$ Million)
Table 77. Becton, Dickinson and Company Recent Development
Table 78. Bio-Rad Laboratories, Inc. Company Details
Table 79. Bio-Rad Laboratories, Inc. Business Overview
Table 80. Bio-Rad Laboratories, Inc. Proteomic Biomarker Product
Table 81. Bio-Rad Laboratories, Inc. Revenue in Proteomic Biomarker Business (2020-2025) & (US$ Million)
Table 82. Bio-Rad Laboratories, Inc. Recent Development
Table 83. Bio-Techne Company Details
Table 84. Bio-Techne Business Overview
Table 85. Bio-Techne Proteomic Biomarker Product
Table 86. Bio-Techne Revenue in Proteomic Biomarker Business (2020-2025) & (US$ Million)
Table 87. Bio-Techne Recent Development
Table 88. Bruker Company Details
Table 89. Bruker Business Overview
Table 90. Bruker Proteomic Biomarker Product
Table 91. Bruker Revenue in Proteomic Biomarker Business (2020-2025) & (US$ Million)
Table 92. Bruker Recent Development
Table 93. C2N Diagnostics Company Details
Table 94. C2N Diagnostics Business Overview
Table 95. C2N Diagnostics Proteomic Biomarker Product
Table 96. C2N Diagnostics Revenue in Proteomic Biomarker Business (2020-2025) & (US$ Million)
Table 97. C2N Diagnostics Recent Development
Table 98. Cepheid (Danaher) Company Details
Table 99. Cepheid (Danaher) Business Overview
Table 100. Cepheid (Danaher) Proteomic Biomarker Product
Table 101. Cepheid (Danaher) Revenue in Proteomic Biomarker Business (2020-2025) & (US$ Million)
Table 102. Cepheid (Danaher) Recent Development
Table 103. Diadem Diagnostics Company Details
Table 104. Diadem Diagnostics Business Overview
Table 105. Diadem Diagnostics Proteomic Biomarker Product
Table 106. Diadem Diagnostics Revenue in Proteomic Biomarker Business (2020-2025) & (US$ Million)
Table 107. Diadem Diagnostics Recent Development
Table 108. Eve Technologies Company Details
Table 109. Eve Technologies Business Overview
Table 110. Eve Technologies Proteomic Biomarker Product
Table 111. Eve Technologies Revenue in Proteomic Biomarker Business (2020-2025) & (US$ Million)
Table 112. Eve Technologies Recent Development
Table 113. Fluidic Analytics Company Details
Table 114. Fluidic Analytics Business Overview
Table 115. Fluidic Analytics Proteomic Biomarker Product
Table 116. Fluidic Analytics Revenue in Proteomic Biomarker Business (2020-2025) & (US$ Million)
Table 117. Fluidic Analytics Recent Development
Table 118. Fujirebio Company Details
Table 119. Fujirebio Business Overview
Table 120. Fujirebio Proteomic Biomarker Product
Table 121. Fujirebio Revenue in Proteomic Biomarker Business (2020-2025) & (US$ Million)
Table 122. Fujirebio Recent Development
Table 123. Hybrigenics Services Company Details
Table 124. Hybrigenics Services Business Overview
Table 125. Hybrigenics Services Proteomic Biomarker Product
Table 126. Hybrigenics Services Revenue in Proteomic Biomarker Business (2020-2025) & (US$ Million)
Table 127. Hybrigenics Services Recent Development
Table 128. Luminex Corp (DiaSorin) Company Details
Table 129. Luminex Corp (DiaSorin) Business Overview
Table 130. Luminex Corp (DiaSorin) Proteomic Biomarker Product
Table 131. Luminex Corp (DiaSorin) Revenue in Proteomic Biomarker Business (2020-2025) & (US$ Million)
Table 132. Luminex Corp (DiaSorin) Recent Development
Table 133. NanoDx Company Details
Table 134. NanoDx Business Overview
Table 135. NanoDx Proteomic Biomarker Product
Table 136. NanoDx Revenue in Proteomic Biomarker Business (2020-2025) & (US$ Million)
Table 137. NanoDx Recent Development
Table 138. Nautilus Biotechnology Company Details
Table 139. Nautilus Biotechnology Business Overview
Table 140. Nautilus Biotechnology Proteomic Biomarker Product
Table 141. Nautilus Biotechnology Revenue in Proteomic Biomarker Business (2020-2025) & (US$ Million)
Table 142. Nautilus Biotechnology Recent Development
Table 143. Nicoya Company Details
Table 144. Nicoya Business Overview
Table 145. Nicoya Proteomic Biomarker Product
Table 146. Nicoya Revenue in Proteomic Biomarker Business (2020-2025) & (US$ Million)
Table 147. Nicoya Recent Development
Table 148. Olink Company Details
Table 149. Olink Business Overview
Table 150. Olink Proteomic Biomarker Product
Table 151. Olink Revenue in Proteomic Biomarker Business (2020-2025) & (US$ Million)
Table 152. Olink Recent Development
Table 153. Qiagen Company Details
Table 154. Qiagen Business Overview
Table 155. Qiagen Proteomic Biomarker Product
Table 156. Qiagen Revenue in Proteomic Biomarker Business (2020-2025) & (US$ Million)
Table 157. Qiagen Recent Development
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
Table 161. Authors List of This Report
List of Figures
Figure 1. Proteomic Biomarker Picture
Figure 2. Global Proteomic Biomarker Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Proteomic Biomarker Market Share by Type: 2024 VS 2031
Figure 4. Mass spectrometry Features
Figure 5. Chromatography Features
Figure 6. Blotting Features
Figure 7. Others Features
Figure 8. Global Proteomic Biomarker Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Proteomic Biomarker Market Share by Application: 2024 VS 2031
Figure 10. Bio Industry Case Studies
Figure 11. Medical Industry Case Studies
Figure 12. Others Case Studies
Figure 13. Proteomic Biomarker Report Years Considered
Figure 14. Global Proteomic Biomarker Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Proteomic Biomarker Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Proteomic Biomarker Market Share by Region: 2024 VS 2031
Figure 17. Global Proteomic Biomarker Market Share by Players in 2024
Figure 18. Global Top Proteomic Biomarker Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Proteomic Biomarker as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Proteomic Biomarker Revenue in 2024
Figure 20. North America Proteomic Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Proteomic Biomarker Market Share by Country (2020-2031)
Figure 22. United States Proteomic Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Proteomic Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Proteomic Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Proteomic Biomarker Market Share by Country (2020-2031)
Figure 26. Germany Proteomic Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Proteomic Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Proteomic Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Proteomic Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Proteomic Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Proteomic Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Proteomic Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Proteomic Biomarker Market Share by Region (2020-2031)
Figure 34. China Proteomic Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Proteomic Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Proteomic Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Proteomic Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Proteomic Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Proteomic Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Proteomic Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Proteomic Biomarker Market Share by Country (2020-2031)
Figure 42. Mexico Proteomic Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Proteomic Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Proteomic Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Proteomic Biomarker Market Share by Country (2020-2031)
Figure 46. Turkey Proteomic Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Proteomic Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Proteomic Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Abbott Laboratories Revenue Growth Rate in Proteomic Biomarker Business (2020-2025)
Figure 50. Agilent/Dako Revenue Growth Rate in Proteomic Biomarker Business (2020-2025)
Figure 51. Amprion Revenue Growth Rate in Proteomic Biomarker Business (2020-2025)
Figure 52. BasePair Biotechnologies Revenue Growth Rate in Proteomic Biomarker Business (2020-2025)
Figure 53. Beckman Coulter Diagnostics Revenue Growth Rate in Proteomic Biomarker Business (2020-2025)
Figure 54. Becton, Dickinson and Company Revenue Growth Rate in Proteomic Biomarker Business (2020-2025)
Figure 55. Bio-Rad Laboratories, Inc. Revenue Growth Rate in Proteomic Biomarker Business (2020-2025)
Figure 56. Bio-Techne Revenue Growth Rate in Proteomic Biomarker Business (2020-2025)
Figure 57. Bruker Revenue Growth Rate in Proteomic Biomarker Business (2020-2025)
Figure 58. C2N Diagnostics Revenue Growth Rate in Proteomic Biomarker Business (2020-2025)
Figure 59. Cepheid (Danaher) Revenue Growth Rate in Proteomic Biomarker Business (2020-2025)
Figure 60. Diadem Diagnostics Revenue Growth Rate in Proteomic Biomarker Business (2020-2025)
Figure 61. Eve Technologies Revenue Growth Rate in Proteomic Biomarker Business (2020-2025)
Figure 62. Fluidic Analytics Revenue Growth Rate in Proteomic Biomarker Business (2020-2025)
Figure 63. Fujirebio Revenue Growth Rate in Proteomic Biomarker Business (2020-2025)
Figure 64. Hybrigenics Services Revenue Growth Rate in Proteomic Biomarker Business (2020-2025)
Figure 65. Luminex Corp (DiaSorin) Revenue Growth Rate in Proteomic Biomarker Business (2020-2025)
Figure 66. NanoDx Revenue Growth Rate in Proteomic Biomarker Business (2020-2025)
Figure 67. Nautilus Biotechnology Revenue Growth Rate in Proteomic Biomarker Business (2020-2025)
Figure 68. Nicoya Revenue Growth Rate in Proteomic Biomarker Business (2020-2025)
Figure 69. Olink Revenue Growth Rate in Proteomic Biomarker Business (2020-2025)
Figure 70. Qiagen Revenue Growth Rate in Proteomic Biomarker Business (2020-2025)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed
Table 1. Global Proteomic Biomarker Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Mass spectrometry
Table 3. Key Players of Chromatography
Table 4. Key Players of Blotting
Table 5. Key Players of Others
Table 6. Global Proteomic Biomarker Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Proteomic Biomarker Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Proteomic Biomarker Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Proteomic Biomarker Market Share by Region (2020-2025)
Table 10. Global Proteomic Biomarker Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Proteomic Biomarker Market Share by Region (2026-2031)
Table 12. Proteomic Biomarker Market Trends
Table 13. Proteomic Biomarker Market Drivers
Table 14. Proteomic Biomarker Market Challenges
Table 15. Proteomic Biomarker Market Restraints
Table 16. Global Proteomic Biomarker Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Proteomic Biomarker Market Share by Players (2020-2025)
Table 18. Global Top Proteomic Biomarker Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Proteomic Biomarker as of 2024)
Table 19. Ranking of Global Top Proteomic Biomarker Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Proteomic Biomarker Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Proteomic Biomarker, Headquarters and Area Served
Table 22. Global Key Players of Proteomic Biomarker, Product and Application
Table 23. Global Key Players of Proteomic Biomarker, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Proteomic Biomarker Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Proteomic Biomarker Revenue Market Share by Type (2020-2025)
Table 27. Global Proteomic Biomarker Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Proteomic Biomarker Revenue Market Share by Type (2026-2031)
Table 29. Global Proteomic Biomarker Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Proteomic Biomarker Revenue Market Share by Application (2020-2025)
Table 31. Global Proteomic Biomarker Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Proteomic Biomarker Revenue Market Share by Application (2026-2031)
Table 33. North America Proteomic Biomarker Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Proteomic Biomarker Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Proteomic Biomarker Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Proteomic Biomarker Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Proteomic Biomarker Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Proteomic Biomarker Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Proteomic Biomarker Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Proteomic Biomarker Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Proteomic Biomarker Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Proteomic Biomarker Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Proteomic Biomarker Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Proteomic Biomarker Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Proteomic Biomarker Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Proteomic Biomarker Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Proteomic Biomarker Market Size by Country (2026-2031) & (US$ Million)
Table 48. Abbott Laboratories Company Details
Table 49. Abbott Laboratories Business Overview
Table 50. Abbott Laboratories Proteomic Biomarker Product
Table 51. Abbott Laboratories Revenue in Proteomic Biomarker Business (2020-2025) & (US$ Million)
Table 52. Abbott Laboratories Recent Development
Table 53. Agilent/Dako Company Details
Table 54. Agilent/Dako Business Overview
Table 55. Agilent/Dako Proteomic Biomarker Product
Table 56. Agilent/Dako Revenue in Proteomic Biomarker Business (2020-2025) & (US$ Million)
Table 57. Agilent/Dako Recent Development
Table 58. Amprion Company Details
Table 59. Amprion Business Overview
Table 60. Amprion Proteomic Biomarker Product
Table 61. Amprion Revenue in Proteomic Biomarker Business (2020-2025) & (US$ Million)
Table 62. Amprion Recent Development
Table 63. BasePair Biotechnologies Company Details
Table 64. BasePair Biotechnologies Business Overview
Table 65. BasePair Biotechnologies Proteomic Biomarker Product
Table 66. BasePair Biotechnologies Revenue in Proteomic Biomarker Business (2020-2025) & (US$ Million)
Table 67. BasePair Biotechnologies Recent Development
Table 68. Beckman Coulter Diagnostics Company Details
Table 69. Beckman Coulter Diagnostics Business Overview
Table 70. Beckman Coulter Diagnostics Proteomic Biomarker Product
Table 71. Beckman Coulter Diagnostics Revenue in Proteomic Biomarker Business (2020-2025) & (US$ Million)
Table 72. Beckman Coulter Diagnostics Recent Development
Table 73. Becton, Dickinson and Company Company Details
Table 74. Becton, Dickinson and Company Business Overview
Table 75. Becton, Dickinson and Company Proteomic Biomarker Product
Table 76. Becton, Dickinson and Company Revenue in Proteomic Biomarker Business (2020-2025) & (US$ Million)
Table 77. Becton, Dickinson and Company Recent Development
Table 78. Bio-Rad Laboratories, Inc. Company Details
Table 79. Bio-Rad Laboratories, Inc. Business Overview
Table 80. Bio-Rad Laboratories, Inc. Proteomic Biomarker Product
Table 81. Bio-Rad Laboratories, Inc. Revenue in Proteomic Biomarker Business (2020-2025) & (US$ Million)
Table 82. Bio-Rad Laboratories, Inc. Recent Development
Table 83. Bio-Techne Company Details
Table 84. Bio-Techne Business Overview
Table 85. Bio-Techne Proteomic Biomarker Product
Table 86. Bio-Techne Revenue in Proteomic Biomarker Business (2020-2025) & (US$ Million)
Table 87. Bio-Techne Recent Development
Table 88. Bruker Company Details
Table 89. Bruker Business Overview
Table 90. Bruker Proteomic Biomarker Product
Table 91. Bruker Revenue in Proteomic Biomarker Business (2020-2025) & (US$ Million)
Table 92. Bruker Recent Development
Table 93. C2N Diagnostics Company Details
Table 94. C2N Diagnostics Business Overview
Table 95. C2N Diagnostics Proteomic Biomarker Product
Table 96. C2N Diagnostics Revenue in Proteomic Biomarker Business (2020-2025) & (US$ Million)
Table 97. C2N Diagnostics Recent Development
Table 98. Cepheid (Danaher) Company Details
Table 99. Cepheid (Danaher) Business Overview
Table 100. Cepheid (Danaher) Proteomic Biomarker Product
Table 101. Cepheid (Danaher) Revenue in Proteomic Biomarker Business (2020-2025) & (US$ Million)
Table 102. Cepheid (Danaher) Recent Development
Table 103. Diadem Diagnostics Company Details
Table 104. Diadem Diagnostics Business Overview
Table 105. Diadem Diagnostics Proteomic Biomarker Product
Table 106. Diadem Diagnostics Revenue in Proteomic Biomarker Business (2020-2025) & (US$ Million)
Table 107. Diadem Diagnostics Recent Development
Table 108. Eve Technologies Company Details
Table 109. Eve Technologies Business Overview
Table 110. Eve Technologies Proteomic Biomarker Product
Table 111. Eve Technologies Revenue in Proteomic Biomarker Business (2020-2025) & (US$ Million)
Table 112. Eve Technologies Recent Development
Table 113. Fluidic Analytics Company Details
Table 114. Fluidic Analytics Business Overview
Table 115. Fluidic Analytics Proteomic Biomarker Product
Table 116. Fluidic Analytics Revenue in Proteomic Biomarker Business (2020-2025) & (US$ Million)
Table 117. Fluidic Analytics Recent Development
Table 118. Fujirebio Company Details
Table 119. Fujirebio Business Overview
Table 120. Fujirebio Proteomic Biomarker Product
Table 121. Fujirebio Revenue in Proteomic Biomarker Business (2020-2025) & (US$ Million)
Table 122. Fujirebio Recent Development
Table 123. Hybrigenics Services Company Details
Table 124. Hybrigenics Services Business Overview
Table 125. Hybrigenics Services Proteomic Biomarker Product
Table 126. Hybrigenics Services Revenue in Proteomic Biomarker Business (2020-2025) & (US$ Million)
Table 127. Hybrigenics Services Recent Development
Table 128. Luminex Corp (DiaSorin) Company Details
Table 129. Luminex Corp (DiaSorin) Business Overview
Table 130. Luminex Corp (DiaSorin) Proteomic Biomarker Product
Table 131. Luminex Corp (DiaSorin) Revenue in Proteomic Biomarker Business (2020-2025) & (US$ Million)
Table 132. Luminex Corp (DiaSorin) Recent Development
Table 133. NanoDx Company Details
Table 134. NanoDx Business Overview
Table 135. NanoDx Proteomic Biomarker Product
Table 136. NanoDx Revenue in Proteomic Biomarker Business (2020-2025) & (US$ Million)
Table 137. NanoDx Recent Development
Table 138. Nautilus Biotechnology Company Details
Table 139. Nautilus Biotechnology Business Overview
Table 140. Nautilus Biotechnology Proteomic Biomarker Product
Table 141. Nautilus Biotechnology Revenue in Proteomic Biomarker Business (2020-2025) & (US$ Million)
Table 142. Nautilus Biotechnology Recent Development
Table 143. Nicoya Company Details
Table 144. Nicoya Business Overview
Table 145. Nicoya Proteomic Biomarker Product
Table 146. Nicoya Revenue in Proteomic Biomarker Business (2020-2025) & (US$ Million)
Table 147. Nicoya Recent Development
Table 148. Olink Company Details
Table 149. Olink Business Overview
Table 150. Olink Proteomic Biomarker Product
Table 151. Olink Revenue in Proteomic Biomarker Business (2020-2025) & (US$ Million)
Table 152. Olink Recent Development
Table 153. Qiagen Company Details
Table 154. Qiagen Business Overview
Table 155. Qiagen Proteomic Biomarker Product
Table 156. Qiagen Revenue in Proteomic Biomarker Business (2020-2025) & (US$ Million)
Table 157. Qiagen Recent Development
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
Table 161. Authors List of This Report
List of Figures
Figure 1. Proteomic Biomarker Picture
Figure 2. Global Proteomic Biomarker Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Proteomic Biomarker Market Share by Type: 2024 VS 2031
Figure 4. Mass spectrometry Features
Figure 5. Chromatography Features
Figure 6. Blotting Features
Figure 7. Others Features
Figure 8. Global Proteomic Biomarker Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Proteomic Biomarker Market Share by Application: 2024 VS 2031
Figure 10. Bio Industry Case Studies
Figure 11. Medical Industry Case Studies
Figure 12. Others Case Studies
Figure 13. Proteomic Biomarker Report Years Considered
Figure 14. Global Proteomic Biomarker Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Proteomic Biomarker Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Proteomic Biomarker Market Share by Region: 2024 VS 2031
Figure 17. Global Proteomic Biomarker Market Share by Players in 2024
Figure 18. Global Top Proteomic Biomarker Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Proteomic Biomarker as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Proteomic Biomarker Revenue in 2024
Figure 20. North America Proteomic Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Proteomic Biomarker Market Share by Country (2020-2031)
Figure 22. United States Proteomic Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Proteomic Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Proteomic Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Proteomic Biomarker Market Share by Country (2020-2031)
Figure 26. Germany Proteomic Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Proteomic Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Proteomic Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Proteomic Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Proteomic Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Proteomic Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Proteomic Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Proteomic Biomarker Market Share by Region (2020-2031)
Figure 34. China Proteomic Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Proteomic Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Proteomic Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Proteomic Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Proteomic Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Proteomic Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Proteomic Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Proteomic Biomarker Market Share by Country (2020-2031)
Figure 42. Mexico Proteomic Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Proteomic Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Proteomic Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Proteomic Biomarker Market Share by Country (2020-2031)
Figure 46. Turkey Proteomic Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Proteomic Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Proteomic Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Abbott Laboratories Revenue Growth Rate in Proteomic Biomarker Business (2020-2025)
Figure 50. Agilent/Dako Revenue Growth Rate in Proteomic Biomarker Business (2020-2025)
Figure 51. Amprion Revenue Growth Rate in Proteomic Biomarker Business (2020-2025)
Figure 52. BasePair Biotechnologies Revenue Growth Rate in Proteomic Biomarker Business (2020-2025)
Figure 53. Beckman Coulter Diagnostics Revenue Growth Rate in Proteomic Biomarker Business (2020-2025)
Figure 54. Becton, Dickinson and Company Revenue Growth Rate in Proteomic Biomarker Business (2020-2025)
Figure 55. Bio-Rad Laboratories, Inc. Revenue Growth Rate in Proteomic Biomarker Business (2020-2025)
Figure 56. Bio-Techne Revenue Growth Rate in Proteomic Biomarker Business (2020-2025)
Figure 57. Bruker Revenue Growth Rate in Proteomic Biomarker Business (2020-2025)
Figure 58. C2N Diagnostics Revenue Growth Rate in Proteomic Biomarker Business (2020-2025)
Figure 59. Cepheid (Danaher) Revenue Growth Rate in Proteomic Biomarker Business (2020-2025)
Figure 60. Diadem Diagnostics Revenue Growth Rate in Proteomic Biomarker Business (2020-2025)
Figure 61. Eve Technologies Revenue Growth Rate in Proteomic Biomarker Business (2020-2025)
Figure 62. Fluidic Analytics Revenue Growth Rate in Proteomic Biomarker Business (2020-2025)
Figure 63. Fujirebio Revenue Growth Rate in Proteomic Biomarker Business (2020-2025)
Figure 64. Hybrigenics Services Revenue Growth Rate in Proteomic Biomarker Business (2020-2025)
Figure 65. Luminex Corp (DiaSorin) Revenue Growth Rate in Proteomic Biomarker Business (2020-2025)
Figure 66. NanoDx Revenue Growth Rate in Proteomic Biomarker Business (2020-2025)
Figure 67. Nautilus Biotechnology Revenue Growth Rate in Proteomic Biomarker Business (2020-2025)
Figure 68. Nicoya Revenue Growth Rate in Proteomic Biomarker Business (2020-2025)
Figure 69. Olink Revenue Growth Rate in Proteomic Biomarker Business (2020-2025)
Figure 70. Qiagen Revenue Growth Rate in Proteomic Biomarker Business (2020-2025)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Allergen Detection Market Research Report 2025
Jun 28, 25
Global Electronic Health Tracking System Market Research Report 2025
Jun 28, 25
Global Speciality Optical Fibers Market Research Report 2025
Jun 28, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232